Pyrazolopyridines as inhibitors of the kinase LRRK2: a patent evaluation (WO2011141756).
Scientific evaluation of a patent aiming for the development of pyrazolopyridine derivatives as LRRK2 kinase inhibitors, a potential therapeutic target for combating Parkinson's disease.